Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece
Globe Newswire•13/11/2026•08:10 ET
0
Key Highlights
- ➤Nanox (NNOX) appoints Medworks as non-exclusive Greek reseller for HealthOST
- ➤HealthOST is FDA-cleared and CE-marked AI-based bone solution
- ➤Agreement builds on Nanox.AI’s existing deployment in Athens
- ➤Medworks brings Greek healthcare sales, technical support and customer-service capabilities
Expert Statements
Erez Meltzer, Chief Executive Officer of Nanox
“Our agreement with Medworks represents an important step in expanding the commercial reach of Nanox.AI”
Building on Nanox.AI's existing deployment in Athens, the agreement supports commercial expansion in Greece through Medworks' established market presence.
PETACH TIKVA, Israel, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox” or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that it has entered into a non-exclusive distribution agreement with Medworks LTD (“Medworks”) to support the commercial expansion of Nanox.AI’s HealthOST solution in Greece.
Get started
Create a free account to read the full story.